심장 마커 검사 시장 : 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The global cardiac marker testing market size is expected to reach USD 17.35 Billion in 2034 from USD 6.91 Billion in 2025, growing at a CAGR of 10.77 during 2026-2034.This market is experiencing strong growth due to the increasing prevalence of cardiovascular diseases and the rising demand for rapid and accurate diagnostic tools. Cardiac marker testing is essential for detecting heart conditions such as myocardial infarction and acute coronary syndrome. The growing emphasis on early diagnosis and timely intervention is significantly contributing to the expansion of this market across hospitals, diagnostic laboratories, and point-of-care settings.

Major drivers include advancements in diagnostic technologies, increasing healthcare expenditure, and growing awareness about heart health. The development of high-sensitivity assays and point-of-care testing devices is improving diagnostic accuracy and reducing turnaround time. Additionally, the expansion of emergency care services and the rising adoption of portable diagnostic devices are supporting market growth. Government initiatives promoting cardiovascular disease prevention and management are also playing a key role.

Looking ahead, the market is expected to benefit from innovations in biomarker research and digital health integration. The use of AI and data analytics in diagnostic processes will enhance accuracy and efficiency. Emerging markets are likely to offer significant growth opportunities due to improving healthcare infrastructure. As the burden of cardiovascular diseases continues to rise, the cardiac marker testing market is poised for sustained expansion.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Product Type

• Reagent and Instrument
• ELISA
• Immunochromatography
• Immunofluorescence
• Chemiluminescence

By Disease Type

• Congestive Heart Failure
• Myocardial Infarction
• Atherosclerosis

By Component

• CK-MB
• Troponin I & T
• Myoglobin
• hsCRP
• IMA
• BNP

By End Use

• Laboratories
• Point-Of-Care Testing
• Academia

COMPANIES PROFILED

• Thermo Fisher Scientific Inc., Tosoh Corporation., Siemens Healthineers AG, Abbott Laboratories, Bio-Rad Laboratories Inc., DiaSorin S.p.A., Becton Dickinson and Company, PerkinElmer Inc., Randox laboratories Ltd., Guangzhou Wondfo Biotech Co. Ltd.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL CARDIAC MARKER TESTING MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product Type
• 4.2. Reagent and Instrument Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. ELISA Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Immunochromatography Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Immunofluorescence Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Chemiluminescence Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL CARDIAC MARKER TESTING MARKET: BY DISEASE TYPE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Disease Type
• 5.2. Congestive Heart Failure Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Myocardial Infarction Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Atherosclerosis Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL CARDIAC MARKER TESTING MARKET: BY COMPONENT 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Component
• 6.2. CK-MB Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Troponin I & T Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Myoglobin Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. hsCRP Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.6. IMA Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.7. BNP Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL CARDIAC MARKER TESTING MARKET: BY END USE 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End Use
• 7.2. Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Point-Of-Care Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Academia Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL CARDIAC MARKER TESTING MARKET: BY REGION 2022-2034 (USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Product Type
  • 8.2.2 By Disease Type
  • 8.2.3 By Component
  • 8.2.4 By End Use
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Product Type
  • 8.3.2 By Disease Type
  • 8.3.3 By Component
  • 8.3.4 By End Use
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Product Type
  • 8.4.2 By Disease Type
  • 8.4.3 By Component
  • 8.4.4 By End Use
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Product Type
  • 8.5.2 By Disease Type
  • 8.5.3 By Component
  • 8.5.4 By End Use
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Product Type
  • 8.6.2 By Disease Type
  • 8.6.3 By Component
  • 8.6.4 By End Use
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL CARDIAC MARKER TESTING INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Thermo Fisher Scientific Inc
  • 10.2.2 Tosoh Corporation
  • 10.2.3 Siemens Healthineers AG
  • 10.2.4 Abbott Laboratories
  • 10.2.5 Bio-Rad Laboratories Inc
  • 10.2.6 DiaSorin S.p.A
  • 10.2.7 Becton Dickinson And Company
  • 10.2.8 PerkinElmer Inc
  • 10.2.9 Randox Laboratories Ltd
  • 10.2.10 Guangzhou Wondfo Biotech Co. Ltd